Company intelligence / Profile preview

Vitruvias Therapeutics

Auburn, Alabama, United Statesvitruvias.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Vitruvias Therapeutics markets several approved generic prescription products in the U.S. It has launched first-to-market generics such as Amicar tablets and licensed ANDAs for complex oral solids like potassium chloride ER. The company partners with international manufacturers to bring high-barrier or niche generics to the U.S. market. Recent collaborations include commercialization of racemic ketamine injection products with PharmaTher Holdings.

Therapeutic areas
NeurologyCardiovascularNephrologyHematology
Modalities
Small moleculesOral solidsSterile injectablesSemi-solidsTopical generics
Industry
Biotech
02

Drug pipeline

5 assets

propafenone hydrochloride

Commercial
Indications
Ventricular tachycardia, Supraventricular arrhythmias, Atrial fibrillation, Atrial flutter

4 more assets in the full pipeline.

03

Partnerships

PharmaTher Holdings Inc. for U.S. commercialization of KETARX racemic ketamine injectionBora Pharmaceuticals for manufacturing potassium chloride ER capsulesSinotherapeutics for propafenone ER launch in the U.S.

Beyond the preview

Go deeper on Vitruvias Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitruvias Therapeutics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call